FindTrial
Sign In

The use of remifentanyl and sufentanyl in obstetrical general anesthesia induction and their effect on neonate

The use of remifentanyl and sufentanyl in obstetrical general anesthesia induction and their effect on neonate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019636
Enrollment
Unknown
Registered
2018-11-20
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory condition of neonates

Interventions

Group 2:used sufentanyl in the induction of general anesthesia
Group 1:used remifentanyl in the induction of general anesthesia

Sponsors

International Peace Maternity and Child Health Hospital-Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: The patients underwent general anesthesia during cesarean section and used remifentanyl or sufentanyl in the induction of general anesthesia during 2013-2018.

Exclusion criteria

Exclusion criteria: Exclude emergency cesarean section, ASA>3, multifetation, used other analgesics(such as ketamine) or combined two or more analgesics during induction of general anesthesia. Exclude other obstetrical surgeries.

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate;Apgar scores;neonate heart rate;neonate spO2;—

Countries

China

Contacts

Public ContactTao Xu

International Peace Maternity and Child Health Hospital-Shanghai JiaoTong University School of Medicine

towerxutao@163.com+86 18017310165

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026